ARIB | Advanced Research Incubator in Biosciences (ARIB): A centre of excellence for disseminating quality biomedical research and boosting the next research generation for sustainable growth

Summary
Despite the influx of European regional development funds into the Czech Republic including the Central Bohemian Region (CBR), there is not yet a functional transfer environment in which innovation leads to products and services that drive the economic development of the region. This Teaming proposal will address the structural deficiency in the CBR by establishing “ARIB - Advanced Research Incubator in Biosciences”, a unique new institution designed to nurture the research and career development of young researchers who will generate the high quality innovative research findings and inventions needed to fill the newly established infrastructures with life. The source of excellence will be the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, a flagship institute of the Max Planck Society and the excellence will be absorbed by the Institute of Molecular Genetics (IMG) in Prague, the flagship biomedical research institute of the Czech Academy of Sciences. MPI-CBG has a rich research landscape on which to draw examples, and the IMG can provide the best regional structural opportunities to exploit it. The first innovative high potential and synergistic research opportunities have been identified and are elaborated in the proposal. The proximity of Dresden and Prague is the most crucial factor to facilitate the effective transfer of excellence. The proposal seeks funding for preparation of a comprehensive business plan to implement a Teaming for Excellence strategy that will awaken the dormant research synergies between Dresden and Prague. A systematic inventory of the available assets, strengths and weaknesses will identify productive synergies between the two regions that when brought to fruition in ARIB, will serve as success stories for further implementation in the Czech Republic. Thus, ARIB will accelerate discoveries in biomedical research and transfer the results into the fertile environment of the nascent CBR technology cluster.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/763823
Start date: 01-09-2017
End date: 31-08-2018
Total budget - Public funding: 359 207,50 Euro - 359 207,00 Euro
Cordis data

Original description

Despite the influx of European regional development funds into the Czech Republic including the Central Bohemian Region (CBR), there is not yet a functional transfer environment in which innovation leads to products and services that drive the economic development of the region. This Teaming proposal will address the structural deficiency in the CBR by establishing “ARIB - Advanced Research Incubator in Biosciences”, a unique new institution designed to nurture the research and career development of young researchers who will generate the high quality innovative research findings and inventions needed to fill the newly established infrastructures with life. The source of excellence will be the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) in Dresden, a flagship institute of the Max Planck Society and the excellence will be absorbed by the Institute of Molecular Genetics (IMG) in Prague, the flagship biomedical research institute of the Czech Academy of Sciences. MPI-CBG has a rich research landscape on which to draw examples, and the IMG can provide the best regional structural opportunities to exploit it. The first innovative high potential and synergistic research opportunities have been identified and are elaborated in the proposal. The proximity of Dresden and Prague is the most crucial factor to facilitate the effective transfer of excellence. The proposal seeks funding for preparation of a comprehensive business plan to implement a Teaming for Excellence strategy that will awaken the dormant research synergies between Dresden and Prague. A systematic inventory of the available assets, strengths and weaknesses will identify productive synergies between the two regions that when brought to fruition in ARIB, will serve as success stories for further implementation in the Czech Republic. Thus, ARIB will accelerate discoveries in biomedical research and transfer the results into the fertile environment of the nascent CBR technology cluster.

Status

CLOSED

Call topic

WIDESPREAD-04-2017

Update Date

17-05-2024
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.4. SPREADING EXCELLENCE AND WIDENING PARTICIPATION
H2020-EU.4.a. Teaming of excellent research institutions and low performing RDI regions
H2020-WIDESPREAD-04-2017-TeamingPhase1
WIDESPREAD-04-2017 Teaming Phase 1